Wen Dai

2.1k total citations
85 papers, 1.4k citations indexed

About

Wen Dai is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Epidemiology. According to data from OpenAlex, Wen Dai has authored 85 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 24 papers in Endocrinology, Diabetes and Metabolism and 22 papers in Epidemiology. Recurrent topics in Wen Dai's work include Lipoproteins and Cardiovascular Health (11 papers), Adipokines, Inflammation, and Metabolic Diseases (11 papers) and Liver Disease Diagnosis and Treatment (11 papers). Wen Dai is often cited by papers focused on Lipoproteins and Cardiovascular Health (11 papers), Adipokines, Inflammation, and Metabolic Diseases (11 papers) and Liver Disease Diagnosis and Treatment (11 papers). Wen Dai collaborates with scholars based in China, United States and Taiwan. Wen Dai's co-authors include Junke Long, Yawen Zheng, Shui-Ping Zhao, Rui Peng, Shui‐Ping Zhao, Chuandong Wei, Yan Li, Lale Özcan, Yuan‐Jian Li and Yan Li and has published in prestigious journals such as Blood, PLoS ONE and Circulation Research.

In The Last Decade

Wen Dai

79 papers receiving 1.4k citations

Peers

Wen Dai
Wen‐Jane Lee Taiwan
Xu Teng China
Bogna Grygiel‐Górniak Poland
Modar Kassan United States
Harvest F. Gu Sweden
Yi‐Jen Hung Taiwan
Víctor M. Víctor Spain
Dong‐Il Kim South Korea
Krzysztof Łabuzek Poland
Anna Jamróz-Wiśniewska Poland
Wen‐Jane Lee Taiwan
Wen Dai
Citations per year, relative to Wen Dai Wen Dai (= 1×) peers Wen‐Jane Lee

Countries citing papers authored by Wen Dai

Since Specialization
Citations

This map shows the geographic impact of Wen Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen Dai more than expected).

Fields of papers citing papers by Wen Dai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen Dai. The network helps show where Wen Dai may publish in the future.

Co-authorship network of co-authors of Wen Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Wen Dai. A scholar is included among the top collaborators of Wen Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen Dai. Wen Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dai, Jin, Wen Dai, & Wenqing Li. (2025). Association of muscle-strengthening and aerobic physical activity with all-cause, cardiovascular disease, and cancer mortality in US adults with diabetes. European Journal of Preventive Cardiology. 2 indexed citations
2.
Wang, Xiaowen, et al.. (2025). ApoA5-CIDEC axis regulates hepatic lipid metabolism, inflammation, and fibrosis in MASLD. Journal of Molecular Medicine. 104(1). 3–3.
3.
Luo, Miyang, et al.. (2024). Integrative metabolomics highlights gut microbiota metabolites as novel NAFLD-related candidate biomarkers in children. Microbiology Spectrum. 12(4). e0523022–e0523022. 8 indexed citations
4.
Tao, Jun, Wen Dai, Hang Liu, et al.. (2024). Role of intestinal testosterone-degrading bacteria and 3/17β-HSD in the pathogenesis of testosterone deficiency-induced hyperlipidemia in males. npj Biofilms and Microbiomes. 10(1). 123–123. 5 indexed citations
5.
Dai, Wen & Sandra S. Albrecht. (2024). Sitting Time and Its Interaction With Physical Activity in Relation to All-Cause and Heart Disease Mortality in U.S. Adults With Diabetes. Diabetes Care. 47(10). 1764–1768. 8 indexed citations
6.
Wang, Haibo, Xuan Xiao, Wen Dai, et al.. (2024). Dispel some mist on circulating biopterins: measurement, physiological interval and pathophysiological implication. Metabolomics. 20(4). 74–74. 3 indexed citations
7.
Chen, Wenjing, Jue Zhang, Dandan Wang, et al.. (2024). CD36 restricts lipid-associated macrophages accumulation in white adipose tissues during atherogenesis. Frontiers in Cardiovascular Medicine. 11. 1436865–1436865. 1 indexed citations
8.
Dai, Jin, Wen Dai, & Wenqing Li. (2023). Trends in physical activity and sedentary time among U.S. adults with diabetes: 2007–2020. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 17(10). 102874–102874. 8 indexed citations
9.
Tao, Jun, Yun Huang, Yan Li, & Wen Dai. (2023). Platelet-to-lymphocyte ratio and serum hsCRP levels in third trimester and adverse pregnancy outcomes in women with gestational diabetes mellitus. Scientific Reports. 13(1). 20963–20963. 5 indexed citations
10.
Dai, Wen, et al.. (2023). Tale of two systems: the intertwining duality of fibrinolysis and lipoprotein metabolism. Journal of Thrombosis and Haemostasis. 21(10). 2679–2696. 4 indexed citations
11.
Dai, Wen, Hayley Lund, Kristen Osinski, et al.. (2022). The correlations among racial/ethnic groups, hypertriglyceridemia, thrombosis, and mortality in hospitalized patients with COVID-19. Best Practice & Research Clinical Haematology. 35(3). 101386–101386. 4 indexed citations
12.
Dai, Wen, Hayley Lund, Yiliang Chen, et al.. (2021). Hypertriglyceridemia during hospitalization independently associates with mortality in patients with COVID-19. Journal of clinical lipidology. 15(5). 724–731. 13 indexed citations
13.
Dai, Wen, Ziyu Zhang, & Shui‐Ping Zhao. (2021). The Risk of Type 2 Diabetes and Coronary Artery Disease in Non-obese Patients With Non-alcoholic Fatty Liver Disease: A Cohort Study. Frontiers in Cardiovascular Medicine. 8. 680664–680664. 7 indexed citations
14.
Dai, Wen, et al.. (2021). Hsa_circ_0010220 regulates miR-198/Syntaxin 6 axis to promote osteosarcoma progression. Journal of bone oncology. 28. 100360–100360. 8 indexed citations
15.
Spolitu, Stefano, Haruka Okamoto, Wen Dai, et al.. (2019). Hepatic Glucagon Signaling Regulates PCSK9 and Low-Density Lipoprotein Cholesterol. Circulation Research. 124(1). 38–51. 49 indexed citations
16.
Peng, Rui, Wen Dai, & Yan Li. (2018). High serum levels of tenascin-C are associated with suicide attempts in depressed patients. Psychiatry Research. 268. 60–64. 5 indexed citations
17.
Spolitu, Stefano, Haruka Okamoto, Wen Dai, et al.. (2018). Hepatic Glucagon Signaling Regulates PCSK9 and LDL-Cholesterol. Circulation Research. 1 indexed citations
18.
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wen‐Jane Lee Breakdown of academic impact, for papers by Xu Teng Breakdown of academic impact, for papers by Bogna Grygiel‐Górniak Breakdown of academic impact, for papers by Modar Kassan Breakdown of academic impact, for papers by Harvest F. Gu Breakdown of academic impact, for papers by Yi‐Jen Hung Breakdown of academic impact, for papers by Víctor M. Víctor Breakdown of academic impact, for papers by Dong‐Il Kim Breakdown of academic impact, for papers by Krzysztof Łabuzek Breakdown of academic impact, for papers by Anna Jamróz-Wiśniewska
Rankless by CCL
2026